TMC Life Sciences suspends GCEO; appoints temporary replacement


TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
TMC Life Sciences , CEO , Melvin Heng Jun Li ,

Next In Business News

Shares retreat as techs extend losses, US strikes on Iran lift oil
FBM KLCI falls as high US inflation data weighs on sentiment
Trading ideas: Rohas, OGX, ISF, Gamuda, Dayang, Ann Joo, ABMB, Maybank, Tune, Amway, Scientex
Rohas wins RM42mil TNB deal
OGX unit wins RM97mil data centre contract
SMEs to gain from Alliance Bank, CGC tie-up
PETRONAS signs 20-year LNG deal with Japan’s JERA
Amway Malaysia appoints Leng Kek Mun as MD
Former Karex CFO charged with insider trading
Pentech upbeat on prospects amid digitalisation push

Others Also Read